LINC01346: A Promising RNA Target for Drug Inhibition (G728716)

Target Name: LINC01346

NCBI ID: G728716

LINC01346

Other Name(s): long intergenic non-protein coding RNA 1346 | Long intergenic non-protein coding RNA 1346

LINC01346: A Promising RNA Target for Drug Inhibition

LINC01346 is a long intergenic non-protein coding RNA (lncRNA) with a length of approximately 212 nucleotides. It is a non-coding RNA molecule that is derived from the genomic DNA and is expressed in various cell types of the body.

The function of LINC01346 is not well understood, but it is known to play a role in the regulation of gene expression. LncRNA are known as non-coding RNAs that are not translated into proteins but have regulatory functions. These non-coding RNAs can interact with protein-coding RNAs to either activate or inhibit their translation into protein.

LINC01346 is a perfect candidate as a drug target or biomarker due to its unique function and its potential to regulate cellular processes. The use of RNA-based therapies is becoming increasingly popular in the field of medicine, and LINC01346 could be a valuable tool in this field.

One of the advantages of using RNA-based therapies is their ability to specifically target and suppress the expression of genes that are involved in disease. LINC01346 has been shown to play a role in the regulation of gene expression and has been linked to various diseases, including cancer, neurodegenerative diseases, and mental health conditions.

LINC01346 has also been shown to have a direct impact on cellular signaling pathways. LncRNA have been shown to play a critical role in regulating the expression of genes involved in cellular signaling pathways, including TGF-β signaling pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases.

Another potential application of LINC01346 as a drug target is its role in the regulation of cellular apoptosis. LncRNA have been shown to play a critical role in regulating cell apoptosis, a process that is involved in the natural death of cells. This regulation is important for maintaining tissue homeostasis and for the development and repair of tissues.

LINC01346 has also been shown to play a role in the regulation of cellular immune responses. LncRNA have been shown to regulate the expression of genes involved in the immune response, including the regulation of T cell development and function. This regulation is important for the development and function of the immune system, and is a key factor in the regulation of many diseases.

In conclusion, LINC01346 is a unique and promising candidate for drug targeting and biomarker. Its role in the regulation of gene expression and cellular signaling pathways makes it an attractive target for small molecule inhibitors. Further studies are needed to fully understand the function of LINC01346 and its potential applications in medicine.

Protein Name: Long Intergenic Non-protein Coding RNA 1346

The "LINC01346 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01346 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets